AUDHYA PAUL K. (Chief Medical Officer) sold 1.5% of their position (2.24K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $60.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/27/2026ACC: 0001860131-26-000008
Officer· Chief Medical Officer
Since May 2021
-2.24K
Net shares
Net seller
$60.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 7.24K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
3.4%
5/22/2026
147.50K→152.50K
Common Stock
Direct
Shares
−2.24K
Price / share
$26.78
Trade value
$59.96K
% of position
1.5%
5/26/2026
152.50K→150.26K
Total
Net shares
+2.76K
Net value
-$59.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2026 | M · Option Exercise | +5K | — | — | 3.4% | 147.50K | 152.50K |
| Common Stock Direct | 5/26/2026 | S · Sale | −2.24K | $26.78 | $59.96K | 1.5% | 152.50K | 150.26K |
| Total | +2.76K | -$59.96K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
40K
Exercisable
—
5/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock5K shares | 5/22/2026 | M · Option Exercise | −5K | — | 40K |